• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝星状细胞来源的肌成纤维细胞在肝纤维化中的双重模式转换。

The Dual-Mode Transition of Myofibroblasts Derived from Hepatic Stellate Cells in Liver Fibrosis.

机构信息

Department of General Surgery, The First Hospital of Lanzhou University, Lanzhou 730000, China.

The School of Medical, Lanzhou University, Lanzhou 730000, China.

出版信息

Int J Mol Sci. 2023 Oct 23;24(20):15460. doi: 10.3390/ijms242015460.

DOI:10.3390/ijms242015460
PMID:37895138
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10607848/
Abstract

Hepatic stellate cells (HSCs) are the key promoters of liver fibrosis. In response to liver-fibrosis-inducing factors, HSCs express alpha smooth muscle actin (α-SMA) and obtain myofibroblast phenotype. Collagen secretion and high expression of α-SMA with related high cell tension and migration limitation are the main characteristics of myofibroblasts. How these two characteristics define the role of myofibroblasts in the initiation and progression of liver fibrosis is worth exploring. From this perspective, we explored the correlation between α-SMA expression and collagen secretion in myofibroblasts and the characteristics of collagen deposition in liver fibrosis. Based on a reasonable hypothesis and experimental verification, we believe that the myofibroblast with the α-SMAcollagen model do not effectively explain the initial stage and progression characteristics of liver fibrosis. Therefore, we propose a myofibroblast dual-mode transition model in fibrotic liver (DMTM model). In the DMTM model, myofibroblasts have dual modes. Myofibroblasts obtain enhanced α-SMA expression, accompanied by collagen expression inhibition in the high-concentration region of TGF-β. At the edge of the TGF-β positive region, myofibroblasts convert to a high-migration and high-collagen secretion phenotype. This model reasonably explains collagen deposition and expansion in the initial stage of liver fibrosis.

摘要

肝星状细胞(HSCs)是肝纤维化的关键促进因素。在肝纤维化诱导因子的作用下,HSCs 表达α平滑肌肌动蛋白(α-SMA)并获得肌成纤维细胞表型。胶原分泌和α-SMA 的高表达以及相关的高细胞张力和迁移受限是肌成纤维细胞的主要特征。这些两个特征如何定义肌成纤维细胞在肝纤维化的起始和进展中的作用值得探讨。从这个角度出发,我们探讨了肌成纤维细胞中α-SMA 表达与胶原分泌之间的相关性以及肝纤维化中胶原沉积的特征。基于合理的假设和实验验证,我们认为α-SMA 胶原模型的肌成纤维细胞并不能有效解释肝纤维化的初始阶段和进展特征。因此,我们提出了纤维化肝脏中肌成纤维细胞的双重模式转换模型(DMTM 模型)。在 DMTM 模型中,肌成纤维细胞具有双重模式。肌成纤维细胞获得增强的α-SMA 表达,同时在 TGF-β高浓度区域抑制胶原表达。在 TGF-β阳性区域的边缘,肌成纤维细胞转换为高迁移和高胶原分泌表型。该模型合理地解释了肝纤维化初始阶段的胶原沉积和扩张。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16f4/10607848/fea4ee3d1323/ijms-24-15460-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16f4/10607848/45eb93229f7f/ijms-24-15460-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16f4/10607848/2b8473036a12/ijms-24-15460-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16f4/10607848/fea4ee3d1323/ijms-24-15460-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16f4/10607848/45eb93229f7f/ijms-24-15460-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16f4/10607848/2b8473036a12/ijms-24-15460-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16f4/10607848/fea4ee3d1323/ijms-24-15460-g003.jpg

相似文献

1
The Dual-Mode Transition of Myofibroblasts Derived from Hepatic Stellate Cells in Liver Fibrosis.肝星状细胞来源的肌成纤维细胞在肝纤维化中的双重模式转换。
Int J Mol Sci. 2023 Oct 23;24(20):15460. doi: 10.3390/ijms242015460.
2
Physalin D attenuates hepatic stellate cell activation and liver fibrosis by blocking TGF-β/Smad and YAP signaling.岩白菜素 D 通过阻断 TGF-β/Smad 和 YAP 信号通路抑制肝星状细胞激活和肝纤维化。
Phytomedicine. 2020 Nov;78:153294. doi: 10.1016/j.phymed.2020.153294. Epub 2020 Jul 28.
3
miR-144 regulates transforming growth factor-β1 iduced hepatic stellate cell activation in human fibrotic liver.微小RNA-144调节转化生长因子-β1诱导的人纤维化肝脏中肝星状细胞的激活。
Int J Clin Exp Pathol. 2015 Apr 1;8(4):3994-4000. eCollection 2015.
4
Response of Hepatic Stellate Cells to TGFB1 Differs from the Response of Myofibroblasts. Decorin Protects against the Action of Growth Factor.肝星状细胞对转化生长因子β1(TGFB1)的反应不同于肌成纤维细胞。核心蛋白聚糖可抵御生长因子的作用。
Pathol Oncol Res. 2017 Apr;23(2):287-294. doi: 10.1007/s12253-016-0095-0. Epub 2016 Aug 5.
5
Single Cell RNA Sequencing Identifies Subsets of Hepatic Stellate Cells and Myofibroblasts in Liver Fibrosis.单细胞 RNA 测序鉴定肝纤维化中肝星状细胞和肌成纤维细胞亚群。
Cells. 2019 May 24;8(5):503. doi: 10.3390/cells8050503.
6
Focal Adhesion Kinase Regulates Hepatic Stellate Cell Activation and Liver Fibrosis.黏着斑激酶调节肝星状细胞激活和肝纤维化。
Sci Rep. 2017 Jun 22;7(1):4032. doi: 10.1038/s41598-017-04317-0.
7
Hes1, an important gene for activation of hepatic stellate cells, is regulated by Notch1 and TGF-β/BMP signaling.Hes1是激活肝星状细胞的一个重要基因,受Notch1和TGF-β/BMP信号通路调控。
World J Gastroenterol. 2015 Jan 21;21(3):878-87. doi: 10.3748/wjg.v21.i3.878.
8
Proline-rich tyrosine kinase 2 mediates transforming growth factor-beta-induced hepatic stellate cell activation and liver fibrosis.脯氨酸丰富的酪氨酸激酶 2 介导转化生长因子-β诱导的肝星状细胞激活和肝纤维化。
Sci Rep. 2020 Dec 3;10(1):21018. doi: 10.1038/s41598-020-78056-0.
9
Periostin down-regulation attenuates the pro-fibrogenic response of hepatic stellate cells induced by TGF-β1.骨膜蛋白下调可减弱转化生长因子-β1诱导的肝星状细胞促纤维化反应。
J Cell Mol Med. 2015 Oct;19(10):2462-8. doi: 10.1111/jcmm.12636. Epub 2015 Aug 7.
10
Gremlin1 Accelerates Hepatic Stellate Cell Activation Through Upregulation of TGF-Beta Expression.Gremlin1通过上调转化生长因子-β表达加速肝星状细胞激活。
DNA Cell Biol. 2017 Jul;36(7):603-610. doi: 10.1089/dna.2017.3707. Epub 2017 May 3.

引用本文的文献

1
Albumin Reduces Hepatic Steatosis and Inflammation in High-Fat-Diet-Fed Mice.白蛋白可减轻高脂饮食喂养小鼠的肝脏脂肪变性和炎症。
Int J Mol Sci. 2025 Jul 24;26(15):7156. doi: 10.3390/ijms26157156.
2
Cellular crosstalk in fibrosis: insights into macrophage and fibroblast dynamics.纤维化中的细胞间相互作用:对巨噬细胞和成纤维细胞动态变化的见解
J Biol Chem. 2025 May 5:110203. doi: 10.1016/j.jbc.2025.110203.
3
Roles of PDGF/PDGFR signaling in various organs.血小板衍生生长因子/血小板衍生生长因子受体信号通路在各器官中的作用。

本文引用的文献

1
Albumosomes formed by cytoplasmic pre-folding albumin maintain mitochondrial homeostasis and inhibit nonalcoholic fatty liver disease.由细胞质预折叠白蛋白形成的白蛋白体维持线粒体动态平衡并抑制非酒精性脂肪性肝病。
Signal Transduct Target Ther. 2023 Jun 16;8(1):229. doi: 10.1038/s41392-023-01437-0.
2
Roxarsone inhibits hepatic stellate cell activation and ameliorates liver fibrosis by blocking TGF-β1/Smad signaling pathway.罗沙砷酮通过阻断 TGF-β1/Smad 信号通路抑制肝星状细胞活化并改善肝纤维化。
Int Immunopharmacol. 2023 Jan;114:109527. doi: 10.1016/j.intimp.2022.109527. Epub 2022 Dec 19.
3
HBV, mitochondrial stress, and liver fibrosis: chicken or the egg.
Korean J Physiol Pharmacol. 2025 Mar 1;29(2):139-155. doi: 10.4196/kjpp.24.309. Epub 2024 Oct 31.
4
Advances in the understanding of the role and mechanism of action of PFKFB3‑mediated glycolysis in liver fibrosis (Review).PFKFB3 介导的糖酵解在肝纤维化作用和机制研究进展(综述)。
Int J Mol Med. 2024 Dec;54(6). doi: 10.3892/ijmm.2024.5429. Epub 2024 Sep 20.
5
Dahuang Zhechong Pill Alleviates Liver Fibrosis Progression by Regulating p38 MAPK/NF-κ B/TGF-β1 Pathway.大黄䗪虫丸通过调控 p38MAPK/NF-κB/TGF-β1 通路缓解肝纤维化进展。
Chin J Integr Med. 2024 Dec;30(12):1113-1120. doi: 10.1007/s11655-024-3801-x. Epub 2024 Jun 18.
乙肝病毒、线粒体应激与肝纤维化:先有鸡还是先有蛋。
Hepatology. 2023 Apr 1;77(4):1088-1089. doi: 10.1097/HEP.0000000000000031. Epub 2023 Jan 3.
4
Myofibroblast transdifferentiation of keratocytes results in slower migration and lower sensitivity to mesoscale curvatures.角膜细胞的肌成纤维细胞转分化导致迁移速度减慢以及对中尺度曲率的敏感性降低。
Front Cell Dev Biol. 2022 Jul 22;10:930373. doi: 10.3389/fcell.2022.930373. eCollection 2022.
5
Molecular Mechanisms and Potential New Therapeutic Drugs for Liver Fibrosis.肝纤维化的分子机制及潜在新型治疗药物
Front Pharmacol. 2022 Feb 11;13:787748. doi: 10.3389/fphar.2022.787748. eCollection 2022.
6
REDD1 attenuates hepatic stellate cell activation and liver fibrosis via inhibiting of TGF-β/Smad signaling pathway.REDD1 通过抑制 TGF-β/Smad 信号通路来减轻肝星状细胞的激活和肝纤维化。
Free Radic Biol Med. 2021 Nov 20;176:246-256. doi: 10.1016/j.freeradbiomed.2021.10.002. Epub 2021 Oct 3.
7
Immunobiology and pathogenesis of hepatitis B virus infection.乙型肝炎病毒感染的免疫生物学与发病机制
Nat Rev Immunol. 2022 Jan;22(1):19-32. doi: 10.1038/s41577-021-00549-4. Epub 2021 May 17.
8
Natural Products that Target the NLRP3 Inflammasome to Treat Fibrosis.靶向NLRP3炎性小体治疗纤维化的天然产物。
Front Pharmacol. 2020 Dec 17;11:591393. doi: 10.3389/fphar.2020.591393. eCollection 2020.
9
Liver fibrosis: Pathophysiology and clinical implications.肝纤维化:病理生理学与临床意义。
WIREs Mech Dis. 2021 Jan;13(1):e1499. doi: 10.1002/wsbm.1499. Epub 2020 Jul 26.
10
Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives.肝纤维化:机制概念与治疗视角。
Cells. 2020 Apr 3;9(4):875. doi: 10.3390/cells9040875.